University of Texas Southwestern Medical Center: Carcinoma, Hepatocellular trials
The registry lists 19 Carcinoma, Hepatocellular studies with University of Texas Southwestern Medical Center as lead sponsor. 8 are open to participants now and 4 have results posted.
Early Phase 1 1Phase 1 2Phase 2 11Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT07878689Phase 1/2
- Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular CarcinomaRecruitingNCT07689175Phase 2
- THIO and Cadonilimab in Resectable Hepatocellular CarcinomaRecruitingNCT07446257Early Phase 1
- Ligufalimab and Cadonilimab in Advanced Liver CancersRecruitingNCT06789848Phase 2
- CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver NodulesRecruitingNCT06184152Not applicable
- National Liver Cancer Screening TrialRecruitingNCT06084234Phase 4
- EGCG for Hepatocellular Carcinoma ChemopreventionRecruitingNCT06015022Phase 2
- Erlotinib for Hepatocellular Carcinoma ChemopreventionNot yet recruitingNCT04172779Phase 2
- LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCCTerminatedNCT05537402Phase 2Results posted
- Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular CarcinomaTerminatedNCT05249569Phase 2Results posted
- LEE001 and Chemoembolization In Patients With Advanced Hepatocellular CarcinomaTerminatedNCT02524119Phase 2Results posted
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver CancerCompletedNCT01264705Phase 1/2Results posted
- Domvanalimab and Zimberelimab in Advanced Liver CancersActive, not recruitingNCT05724563Phase 2
- Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCCCompletedNCT04459468
- Harms of Hepatocellular Carcinoma SurveillanceCompletedNCT03756051
- Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5CompletedNCT02582918Not applicable
- RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health SystemCompletedNCT02312817Not applicable
- A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of DoxorubicinCompletedNCT02141906Phase 2
- Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable EventsWithdrawnNCT01963949